Our model is predicated on three central elements: partnership with pathologists, quality and service, and growth. We provide an extensive list of benefits to our pathologist partners in the context of a transaction as well as operating the technical operation post-transaction.
Our innovative, industry-first partnership approach allows our partner pathologists to (i) have a liquidity event/sell, (ii) have continued interest/upside to benefit from future growth, (iii) maintain the complexion of their operations, and (iv) preserve their professional independence.
Quality and Service
Most of the laboratories with which we seek to associate already provide quality diagnostic services and exceptional service. We seek to elevate this even further by providing additional tools and resources. From additional technology resources to a broader testing menu, from capital to expertise, our ultimate goal is better healthcare and even more competitive, premier service to our client physicians and their patients.
In order to accelerate growth, we offer a broad array of services to our partner laboratories, including senior management support, access to capital for liquidity and growth, powerful sales & marketing support, extensive and sophisticated IT resources with proprietary LIS and related software, operational know-how and enhancements, managed care contracting expertise, and group purchasing services. We further support our partner laboratories, as needed and desired by them, by providing access to our world-class Centers of Excellence in Molecular Diagnostics, Flow Cytometry, Renal Pathology, Pediatric Pathology, Dermatopathology, Cytology, and Immunopathology.
| Back to Top |